Glycogen synthase kinase-3 beta
Named enzymes, including the metabolising cytochromes and the monoamine oxidases.
- Measurements
- 19
- Compounds
- 4
- Binding constants
- 2
- Median pX
- 5.45
I · Identity
What this target is
Its function as UniProt states it, where in a cell the protein is found, and which cell types and tissues transcribe its gene.
Glycogen synthase kinase-3 beta
Constitutively active protein kinase that acts as a negative regulator in the hormonal control of glucose homeostasis, Wnt signaling and regulation of transcription factors and microtubules, by phosphorylating and inactivating glycogen synthase (GYS1 or GYS2), EIF2B, CTNNB1/beta-catenin, APC, AXIN1, DPYSL2/CRMP2, JUN, NFATC1/NFATC, MAPT/TAU and MACF111430833,12554650,14690523,16484495,1846781,20937854,9072970. Requires primed phosphorylation of the majority of its substrates11430833,16484495. In skeletal muscle, contributes to insulin regulation of glycogen synthesis by phosphorylating and inhibiting GYS1 activity and hence glycogen synthesis8397507. May also mediate the development of insulin resistance by regulating activation of transcription factors8397507. Regulates protein synthesis by controlling the activity of initiation factor 2B (EIF2BE/EIF2B5) in the same manner as glycogen synthase8397507. In Wnt signaling, GSK3B forms a multimeric complex with APC, AXIN1 and CTNNB1/beta-catenin and phosphorylates the N-terminus of CTNNB1 leading to its degradation mediated by ubiquitin/proteasomes12554650. Phosphorylates JUN at sites proximal to its DNA-binding domain, thereby reducing its affinity for DNA1846781. Phosphorylates NFATC1/NFATC on conserved serine residues promoting NFATC1/NFATC nuclear export, shutting off NFATC1/NFATC gene regulation, and thereby opposing the action of calcineurin9072970. Phosphorylates MAPT/TAU on 'Thr-548', decreasing significantly MAPT/TAU ability to bind and stabilize microtubules14690523. MAPT/TAU is the principal component of neurofibrillary tangles in Alzheimer disease14690523. Plays an important role in ERBB2-dependent stabilization of microtubules at the cell cortex20937854. Phosphorylates MACF1, inhibiting its binding to microtubules which is critical for its role in bulge stem cell migration and skin wound repair (By similarity). Probably regulates NF-kappa-B (NFKB1) at the transcriptional level and is required for the NF-kappa-B-mediated anti-apoptotic response to TNF (TNF/TNFA) (By similarity). Negatively regulates replication in pancreatic beta-cells, resulting in apoptosis, loss of beta-cells and diabetes (By similarity). Through phosphorylation of the anti-apoptotic protein MCL1, may control cell apoptosis in response to growth factors deprivation (By similarity). Phosphorylates MUC1 in breast cancer cells, decreasing the interaction of MUC1 with CTNNB1/beta-catenin9819408. Is necessary for the establishment of neuronal polarity and axon outgrowth20067585. Phosphorylates MARK2, leading to inhibition of its activity (By similarity). Phosphorylates SIK1 at 'Thr-182', leading to sustainment of its activity18348280. Phosphorylates ZC3HAV1 which enhances its antiviral activity22514281. Phosphorylates SNAI1, leading to its ubiquitination and proteasomal degradation15448698,15647282,25827072,29059170. Phosphorylates SFPQ at 'Thr-687' upon T-cell activation20932480. Phosphorylates NR1D1 st 'Ser-55' and 'Ser-59' and stabilizes it by protecting it from proteasomal degradation. Regulates the circadian clock via phosphorylation of the major clock components including BMAL1, CLOCK and PER219946213,28903391. Phosphorylates FBXL2 at 'Thr-404' and primes it for ubiquitination by the SCF(FBXO3) complex and proteasomal degradation (By similarity). Phosphorylates CLOCK AT 'Ser-427' and targets it for proteasomal degradation19946213. Phosphorylates BMAL1 at 'Ser-17' and 'Ser-21' and primes it for ubiquitination and proteasomal degradation28903391. Phosphorylates OGT at 'Ser-3' or 'Ser-4' which positively regulates its activity. Phosphorylates MYCN in neuroblastoma cells which may promote its degradation24391509. Regulates the circadian rhythmicity of hippocampal long-term potentiation and BMAL1 and PER2 expression (By similarity). Acts as a regulator of autophagy by mediating phosphorylation of KAT5/TIP60 under starvation conditions, activating KAT5/TIP60 acetyltransferase activity and promoting acetylation of key autophagy regulators, such as ULK1 and RUBCNL/Pacer30704899. Negatively regulates extrinsic apoptotic signaling pathway via death domain receptors. Promotes the formation of an anti-apoptotic complex, made of DDX3X, BRIC2 and GSK3B, at death receptors, including TNFRSF10B. The anti-apoptotic function is most effective with weak apoptotic signals and can be overcome by stronger stimulation18846110. Phosphorylates E2F1, promoting the interaction between E2F1 and USP11, stabilizing E2F1 and promoting its activity17050006,28992046. Phosphorylates mTORC2 complex component RICTOR at 'Ser-1235' in response to endoplasmic stress, inhibiting mTORC221343617. Phosphorylates mTORC2 complex component RICTOR at 'Thr-1695' which facilitates FBXW7-mediated ubiquitination and subsequent degradation of RICTOR25897075. Acts as a negative regulator of smoothened signaling by mediating phosphorylation of GLI2 and GLI3 in absence of smoothened, promoting their processing by the SCF(BTRC) complex16705181. Phosphorylates FXR1, promoting FXR1 ubiquitination by the SCF(FBXO4) complex and FXR1 degradation by the proteasome (By similarity). Phosphorylates interleukin-22 receptor subunit IL22RA1, preventing its proteasomal degradation (By similarity). Phosphorylates and inhibits the CTP synthase and protein-asparagine deamidase activities of CTPS117681942. Phosphorylates DSP at multiple sequential serine residues in the C-terminus tail, promoting its recruitment to developing desmosome cell-cell junctions25733715
Quoted from UniProt’s FUNCTION annotation for P49841 (reviewed). The superscript numbers are UniProt’s own PubMed citations, kept in the sentence and in order, each linking to the paper it names.
What it acts with
STRING’s highest-confidence human functional partners. The combined score mixes several kinds of evidence, so each channel is shown separately — a partner supported by experiment is a different claim from one supported only by text mining, and for a receptor this is where its coupling appears as evidence rather than as assertion.
Where it sits in the cell
- Nucleoplasm
Human Protein Atlas, by antibody immunofluorescence in cell lines — a different assay from the expression figures below, which are RNA.
UniProt, curated Cytoplasm · Nucleus · Cell membrane
Expression by cell type
Single cell type RNA, the 1 highest of those the Human Protein Atlas reports for this gene. Transcript, not protein, and a cell type rather than a tissue.
- Neutrophils760.9 nCPM
II · Anatomy
Where the gene is transcribed
The same two atlases the compound plates use, asked about this gene alone. Brain on the left, peripheral and autonomic tissues on the right.
Brain
basal ganglia: drawn as the caudate nucleus, putamen and globus pallidus.
Measured but not drawn — this anatomogram has no outline for them: retina 21.9, midbrain 9.9, spinal cord 7.9, pituitary gland 6.8.
Body
Square-root ramp · shared scale across both plates
Shading is transcript level — not affinity, and not affinity combined with expression. Outlined but unshaded organs hold none of GSK3B transcript above the atlas’s detection threshold. Anatomy from EMBL-EBI Anatomogram (Apache License 2.0); regions identified by Uberon (uberon.org), CC BY 3.0.
Brain · 10
- retina21.9 nTPM
- cerebral cortex19.9 nTPM
- cerebellum16.5 nTPM
- hypothalamus13.5 nTPM
- hippocampal formation10.3 nTPM
- basal ganglia10.0 nTPM
- midbrain9.9 nTPM
- amygdala9.7 nTPM
- spinal cord7.9 nTPM
- pituitary gland6.8 nTPM
Peripheral and autonomic · 16
- heart muscle17.2 nTPM
- skeletal muscle16.7 nTPM
- small intestine14.5 nTPM
- thyroid gland14.2 nTPM
- lung13.2 nTPM
- adrenal gland12.9 nTPM
- smooth muscle12.5 nTPM
- salivary gland12.4 nTPM
- spleen12.2 nTPM
- stomach 112.0 nTPM
- duodenum11.6 nTPM
- kidney11.3 nTPM
- urinary bladder11.3 nTPM
- liver11.0 nTPM
- colon11.0 nTPM
- pancreas10.1 nTPM
Transcript is not protein. These are RNA levels for GSK3B, shaded on √nTPM so that a three-order range stays legible — on a linear ramp every region but the strongest would read as blank, which looks like absence rather than less. A region carrying no shading is one the atlas reports no consensus value for, not one where the gene is silent. And a gene being transcribed somewhere is not evidence that any compound reaches it. Human Protein Atlas, RNA expression, nTPM (normalized transcripts per million), consensus tissue dataset.
III · Ranking
Compounds by strongest binding constant
One bar per compound: its strongest Ki or Kd at this target, expressed as pX. Compounds measured here only by a functional assay do not appear — they are in the table below.
IV · Evidence
Every measurement at this target
Each row links to the ChEMBL assay it came from.
Equilibrium binding constants 2
Ki and Kd — a concentration at equilibrium. Directly comparable across rows at the same target.
| Target | Class | Type | Value (nM) | pX | Organism | Assay |
|---|---|---|---|---|---|---|
| Glycogen synthase kinase-3 beta | Enzymes | Kd | 3,560 | 5.45 | Homo sapiens | CHEMBL5251694 |
| Glycogen synthase kinase-3 beta | Enzymes | Kd | — no normalized value | — value does not convert to pX | Homo sapiens | CHEMBL5251385 |
Functional readouts 9
IC₅₀, EC₅₀, AC₅₀ and potency. Assay-dependent, and not interchangeable with a binding constant.
| Target | Class | Type | Value (nM) | pX | Organism | Assay |
|---|---|---|---|---|---|---|
| Glycogen synthase kinase-3 beta | Enzymes | IC50 | 350 | 6.46 | Homo sapiens | CHEMBL5235551 |
| Glycogen synthase kinase-3 beta | Enzymes | IC50 | 32,100 | 4.49 | Homo sapiens | CHEMBL6128020 |
| Glycogen synthase kinase-3 beta | Enzymes | IC50 | 32,100 | 4.49 | Homo sapiens | CHEMBL5157290 |
| Glycogen synthase kinase-3 beta | Enzymes | IC50 | — no normalized value | — value does not convert to pX | Homo sapiens | CHEMBL4604955 |
| Glycogen synthase kinase-3 beta | Enzymes | IC50 | — no normalized value | — value does not convert to pX | Homo sapiens | CHEMBL4824378 |
| Glycogen synthase kinase-3 beta | Enzymes | IC50 | — no normalized value | — value does not convert to pX | Homo sapiens | CHEMBL5251374 |
| Glycogen synthase kinase-3 beta | Enzymes | IC50 | — no normalized value | — value does not convert to pX | Homo sapiens | CHEMBL4034242 |
| Glycogen synthase kinase-3 beta | Enzymes | IC50 | — no normalized value | — value does not convert to pX | Homo sapiens | CHEMBL5251691 |
| Glycogen synthase kinase-3 beta | Enzymes | IC50 | — no normalized value | — value does not convert to pX | Homo sapiens | CHEMBL2187127 |
Other measurements 8
Everything else ChEMBL recorded for this compound — percentage inhibition, efficacy, half-life, cytotoxicity. Reported in the assay's own units, which is why no value is converted here.
| Target | Class | Type | Value (nM) | pX | Organism | Assay |
|---|---|---|---|---|---|---|
| Glycogen synthase kinase-3 beta | Enzymes | Inhibition | — no normalized value | — value does not convert to pX | Homo sapiens | CHEMBL4824377 |
| Glycogen synthase kinase-3 beta | Enzymes | Activity | — no normalized value | — value does not convert to pX | Homo sapiens | CHEMBL1060118 |
| Glycogen synthase kinase-3 beta | Enzymes | Activity | — no normalized value | — value does not convert to pX | Homo sapiens | CHEMBL1060118 |
| Glycogen synthase kinase-3 beta | Enzymes | Activity | — no normalized value | — value does not convert to pX | Homo sapiens | CHEMBL1060118 |
| Glycogen synthase kinase-3 beta | Enzymes | Activity | — no normalized value | — value does not convert to pX | Homo sapiens | CHEMBL1060118 |
| Glycogen synthase kinase-3 beta | Enzymes | Activity | — no normalized value | — value does not convert to pX | Homo sapiens | CHEMBL5251388 |
| Glycogen synthase kinase-3 beta | Enzymes | Tm | — no normalized value | — value does not convert to pX | Homo sapiens | CHEMBL5251702 |
| Glycogen synthase kinase-3 beta | Enzymes | Inhibition | — no normalized value | — value does not convert to pX | Homo sapiens | CHEMBL5251704 |